Research on the impact of R&D Expenses and Sales Investmenton the Enterprise Performance?Based on empirical analysis from the GEM Pharmaceutical Industry
Authors
Zhen-Yi Wang, Peng-Tao Zhou, Meng Xie, Yu-Xi Huang
Corresponding Author
Zhen-Yi Wang
Available Online December 2015.
- DOI
- 10.2991/sschd-16.2016.98How to use a DOI?
- Keywords
- R&D expenses; sales investment; enterprises performance; pharmaceutical Industry
- Abstract
Technological innovation and marketing capability are important means for enterprises to enhance the competitive advantage. This paper used the listed companies of the GEM Pharmaceutical Industry as samples, 2012--2014 years as the test period, to examine the relationship between R&D expenses, sales investment and the enterprise performance. We find that R&D expenses has a significant negative correlation with the current enterprise performance and the lagged one period performance, but the correlation with lagged two period performance is not significant;and sales investment has a significant positive correlation with the current enterprise performance.
- Copyright
- © 2016, the Authors. Published by Atlantis Press.
- Open Access
- This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - CONF AU - Zhen-Yi Wang AU - Peng-Tao Zhou AU - Meng Xie AU - Yu-Xi Huang PY - 2015/12 DA - 2015/12 TI - Research on the impact of R&D Expenses and Sales Investmenton the Enterprise Performance?Based on empirical analysis from the GEM Pharmaceutical Industry BT - Proceedings of the 2nd Annual International Conference on Social Science and Contemporary Humanity Development PB - Atlantis Press SP - 496 EP - 503 SN - 2352-5398 UR - https://doi.org/10.2991/sschd-16.2016.98 DO - 10.2991/sschd-16.2016.98 ID - Wang2015/12 ER -